Market Overview

RTI Biologics, Inc. (NASDAQ: RTIX)

2.68 -0.04 (-1.47%)

Analyst Ratings

DateResearch FirmActionCurrentPT
9/17/19Sidoti & Co.Initiates Coverage OnBuy5.0
5/30/19Cantor FitzgeraldInitiates Coverage OnOverweight7.0
7/28/16Craig-HallumDowngradesHold
10/30/15Canaccord GenuityDowngradesHold
5/21/15Sidoti & Co.Initiates Coverage onBuy9.0
10/10/14Canaccord GenuityMaintainsBuy6.0
9/24/14JMP SecuritiesMaintainsMarket Outperform8.0
4/25/14Canaccord GenuityUpgradesBuy5.0
4/25/14Craig-HallumUpgradesBuy5.0
10/21/13Craig-HallumDowngradesHold3.5

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter